Cargando…
ZC3H12A Expression in Different Stages of Colorectal Cancer
Identification of CRC patients with early-stage disease provides the opportunity for curative local resection. However, robust markers for stage I tumor prediction are yet to be developed. We analyzed RNA-sequencing data of 221 CRC samples using the TCGA dataset to identify novel biomarkers for stag...
Autores principales: | Chen, Tao, Du, Di, Chen, Jian, Zhou, Pinghong, Weinstein, John N., Yao, Liqing, Liu, Yuexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508193/ https://www.ncbi.nlm.nih.gov/pubmed/31106233 http://dx.doi.org/10.18632/oncoscience.480 |
Ejemplares similares
-
ZC3H12B/MCPIP2, a new active member of the ZC3H12 family
por: Wawro, Mateusz, et al.
Publicado: (2019) -
Targeted Disruption of MCPIP1/Zc3h12a Results in Fatal Inflammatory Disease
por: Miao, Ruidong, et al.
Publicado: (2013) -
Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2021) -
ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma
por: Gong, Wangang, et al.
Publicado: (2020) -
ZC3H12C expression in dendritic cells is necessary to prevent lymphadenopathy of skin‐draining lymph nodes
por: Clayer, Elise, et al.
Publicado: (2022)